David Taylor-Robinson Selected Research

David Taylor-Robinson Research Topics

5	Infections 01/2022 - 12/2008
5	Urethritis 03/2015 - 02/2003
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 11/2015
2	Type 2 Diabetes Mellitus (MODY) 11/2019 - 01/2016
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Pseudomonas Infections 01/2022
1	Sepsis (Septicemia) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Mental Disorders (Mental Disorder) 11/2020
1	Overweight 11/2020
1	Pediatric Obesity 11/2020
1	Vomiting 01/2019
1	Syphilis 10/2017
1	Diabetes Complications 11/2015
1	Lung Diseases (Lung Disease) 09/2015
1	Reactive Arthritis (Reiter Disease) 03/2015
1	Chronic Disease (Chronic Diseases) 06/2014
1	Bacterial Vaginosis 01/2008
1	Inflammation (Inflammations) 02/2007
1	Myocardial Infarction 08/2005

6	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 08/2005
2	AntibodiesIBA 10/2017 - 02/2003
1	ProcalcitoninIBA 01/2022
1	dornase alfa (Pulmozyme)FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 11/2020
1	Pharmaceutical PreparationsIBA 11/2020
1	Shiga Toxin (Shigella Toxin)IBA 01/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2017
1	Insulin (Novolin)FDA Link 11/2015
1	Complement System Proteins (Complement)IBA 09/2015
1	Immunoglobulin G (IgG)IBA 09/2015
1	Doxycycline (Periostat)FDA LinkGeneric 06/2014
1	TetracyclinesIBA 06/2014
1	Azithromycin (Zithromax)FDA LinkGeneric 06/2014
1	Coloring Agents (Dyes)IBA 11/2012
1	Hormones (Hormone)IBA 01/2008
1	SolutionsIBA 02/2007
1	Chaperonin 60IBA 02/2003